Atorvastatin reduces expression of the CCR2 and MAC-1 receptors on monocytes, and plasma levels of monocyte chemoattractant protein-1 and C-reactive protein, in patients with coronary heart disease

1. Reinares, L.
2. Figueredo, A.
3. Rueda, A.
4. Pontes, J.C.
5. Rodríguez, A.
6. Ruiz-Yagüe, M.
7. Hernández-Presa, M.A.
8. Pueyo, C.
9. Hernández, G.
10. Fernández-Cruz, A.
11. Patiño, R.